Bachelot T - Search Results

1

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.

Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY. Ray-Coquard I, et al. Among authors: bachelot t. J Clin Oncol. 1999 Sep;17(9):2840-6. doi: 10.1200/JCO.1999.17.9.2840. J Clin Oncol. 1999. PMID: 10561360

2

Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.

Ray-Coquard I, Biron P, Bachelot T, Guastalla JP, Catimel G, Merrouche Y, Droz JP, Chauvin F, Blay JY. Ray-Coquard I, et al. Among authors: bachelot t. Cancer. 1998 Jan 1;82(1):134-40. Cancer. 1998. PMID: 9428489

3

The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group.

Blay J, Gomez F, Sebban C, Bachelot T, Biron P, Guglielmi C, Hagenbeek A, Somers R, Chauvin F, Philip T. Blay J, et al. Among authors: bachelot t. Blood. 1998 Nov 15;92(10):3562-8. Blood. 1998. PMID: 9808548 Free article. Clinical Trial.

4

[Cancer immunotherapy: new approaches].

Blay JY, Thomachot MC, Alberti L, Bachelot T, Voorzanger-Rousselot N, Puisieux I, Odin L, Ménétrier-Caux C. Blay JY, et al. Among authors: bachelot t. Bull Cancer. 2000 Jan;87(1):97-106. Bull Cancer. 2000. PMID: 10673638 Free article. Review. French. No abstract available.

5

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials.

Bachelot T, Ray-Coquard I, Catimel G, Ardiet C, Guastalla JP, Dumortier A, Chauvin F, Droz JP, Philip T, Clavel M. Bachelot T, et al. Ann Oncol. 2000 Feb;11(2):151-6. doi: 10.1023/a:1008368319526. Ann Oncol. 2000. PMID: 10761748 Free article.

6

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.

Ray-Coquard I, Ghesquière H, Bachelot T, Borg C, Biron P, Sebban C, LeCesne A, Chauvin F, Blay JY; ELYPSE Study Group. Ray-Coquard I, et al. Among authors: bachelot t. Br J Cancer. 2001 Sep 14;85(6):816-22. doi: 10.1054/bjoc.2001.2011. Br J Cancer. 2001. PMID: 11556830 Free PMC article.

7

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.

Bachelot T, Gomez F, Biron P, Ray-Coquard I, Soler-Michel P, Philip I, Guastalla JP, Rebattu P, Dumortier A, Droz JP, Blay JY. Bachelot T, et al. Br J Cancer. 2002 Nov 4;87(10):1079-85. doi: 10.1038/sj.bjc.6600631. Br J Cancer. 2002. PMID: 12402145 Free PMC article. Clinical Trial.

8

[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].

Bachelot T, Ray-Coquard I, Coeffic D, Barletta H, Gouttebel MC, Mayer B, Muron T, Laroche GD, Vincent M, Farsi F, Philip T. Bachelot T, et al. Bull Cancer. 2002 Oct;89(10):897-903. Bull Cancer. 2002. PMID: 12441282 Free article. Review. French.

9

[Clinical development of anti-angiogenic agents in 2002].

Bachelot T, Jouanneau E, Blay JY. Bachelot T, et al. Bull Cancer. 2003 Jan;90(1):19-23. Bull Cancer. 2003. PMID: 12609800 Free article. Review. French.

10

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.

Ray-Coquard I, Borg C, Bachelot T, Sebban C, Philip I, Clapisson G, Le Cesne A, Biron P, Chauvin F, Blay JY; ELYPSE study group. Ray-Coquard I, et al. Among authors: bachelot t. Br J Cancer. 2003 Jan 27;88(2):181-6. doi: 10.1038/sj.bjc.6600724. Br J Cancer. 2003. PMID: 12610500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters